Last quarter (Q0 0), Rosetta Genomics's total revenue was $870.00K, a decrease of -66.58% from the same quarter last year. In Q0, Rosetta Genomics's net income was $-2.07M. See Rosetta Genomics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 16	Dec 15	Dec 14	Dec 13	Dec 12
Total Revenue	$ 5.49M	$ 9.23M	$ 8.27M	$ 1.33M	$ 405.00K	$ 201.00K
Cost of Revenue	$ 4.86M	$ 7.44M	$ 6.27M	$ 1.31M	$ 709.00K	$ 258.00K
Gross Profit	$ 636.00K	$ 1.79M	$ 2.00M	$ 17.00K	$ -304.00K	$ -57.00K
Operating Expense	$ 13.53M	$ 17.46M	$ 17.87M	$ 14.27M	$ 13.04M	$ 8.21M
Operating Income	$ -12.89M	$ -15.66M	$ -15.88M	$ -14.25M	$ -13.35M	$ -8.27M
Net Non Operating Interest Income Expense	$ -338.00K	$ -591.00K	$ -1.61M	$ -259.00K	$ 177.00K	$ -2.43M
Other Income Expense	-	$ -12.00K	$ 164.00K	$ -410.00K	$ ―	$ ―
Pretax Income	$ -13.23M	$ -16.27M	$ -17.33M	$ -14.51M	$ -13.17M	$ -10.70M
Tax Provision	$ 6.00K	$ -34.00K	$ 19.00K	$ 15.00K	$ ―	$ 0.00
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -14.27M	$ -16.23M	$ -17.34M	$ -14.53M	$ -12.90M	$ -10.46M
Basic EPS	$ -7.75	$ -9.31	$ -13.80	$ -15.48	$ -16.08	$ -28.20
Diluted EPS	$ -7.75	$ -9.31	$ -13.80	$ -15.48	$ -16.08	$ -28.20
Basic Average Shares	$ 7.80M	$ 1.74M	$ 1.26M	$ 936.65K	$ 799.49K	$ 370.70K
Diluted Average Shares	$ 7.87M	$ 1.84M	$ 1.26M	$ 936.65K	$ 799.49K	$ 370.70K
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 18.39M	$ 24.90M	$ 24.14M	$ 15.58M	$ 13.75M	$ 8.47M
Net Income From Continuing And Discontinued Operation	$ -14.27M	$ -16.23M	$ -17.34M	$ -14.53M	$ -12.90M	$ -10.46M
Normalized Income	$ -13.22M	$ -16.22M	$ -17.51M	$ -14.53M	$ -13.17M	$ -10.70M
Interest Expense	$ ―	$ 43.00K	$ 48.00K	$ 39.00K	$ 21.00K	$ 319.00K
EBIT	$ -13.46M	$ -16.22M	$ -17.28M	$ -14.25M	$ -13.15M	$ -10.38M
EBITDA	$ -13.46M	$ -15.32M	$ -16.53M	$ -13.95M	$ -12.85M	$ -10.10M

Currency in USD

Rosetta Genomics Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing